[Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
D000328:Adult; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000150:complications*; D003693:Delirium / Q000188:drug therapy; D003704:Dementia / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D004361:Drug Tolerance; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D010879:Piperazines; D014665:Vasodilator Agents
Résultats de 100 observations concernant l'action du 1035 M.D. sur certains troubles neuro-psychiatriques consécutifs aux déficits circulatoires cérébraux.